MarkGrovesMD

PubMed

• Evidence for increased completed suicide in first-degree relatives of LRRK2 G2019S mutation Parkinson's disease.
  Roberto Angel Ortega, Mark Groves, Anat Mirelman, Roy N. Alcalay, Deborah Raymond, Sonya Elango, Helen Mejia-Santana, Nir Giladi, Karen Marder, Susan B. Bressman, Rach...> ;Journal of Neurology, Neurosurgery, and Psychiatry. 2019 Jul 1
• 1 citations
  The highly anxious individual presenting for Huntington disease-predictive genetic testing: the psychiatrist's role in assessment and counseling.
  Mark Groves> ;Handbook of Clinical Neurology. 2017 Jan 1
• 17 citations
  Psychiatric and Cognitive Effects of Deep Brain Stimulation for Parkinson’s Disease
  Adam Nassery, Christina Palmese, Harini Sarva, Mark Groves, Joan Miravite, Brian Harris Kopell> ;Current Neurology and Neuroscience Reports. 2016 Aug 18
• 12 citations
  Risk Factors for Suicidal Ideation in People at Risk for Huntington's Disease.
  Karen E. Anderson, Shirley Eberly, Mark Groves, Elise Kayson, Karen Marder, Anne B. Young, Ira Shoulson> ;Journal of Huntington's Disease. 2016 Dec 15
• 2 citations
  Clozapine Treatment for Impulse Control Disorders in Parkinson's Disease Patients: A Case Series.
  John W. Liang, Mark Groves, Vicki Shanker> ;Movement Disorders Clinical Practice. 2015 Sep 1
• 9 citations
  Naltrexone for impulse control disorders in Parkinson disease: A placebo-controlled studyAuthor Response
  José Carlos Fernandes Galduróz, John W. Liang, Daniel Weintraub, A. Ramos, Ruth Ferreia Santos-Galduróz, Vicki Shanker, Mark Groves, Kimberly Papay, Sharon X. Xie> ;Neurology. 2015 Mar 31
• 49 citations
  Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis
  Laurent Younes, J. Tilak Ratnanather, Timothy Brown, Elizabeth Aylward, Peg Nopoulos, Hans J. Johnson, Vincent A. Magnotta, Jane S. Paulsen, Russell L. Margolis, Roger...> ;Human Brain Mapping. 2014 Mar 1
• 117 citations
  Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations.
  Roy N. Alcalay, Anat Mirelman, Rachel Saunders-Pullman, Ming X. Tang, Helen Mejia Santana, Deborah Raymond, Ernest Roos, Martha Orbe-Reilly, Tanya Gurevich, Anat Bar S...> ;Movement Disorders. 2013 Dec 1
• 45 citations
  Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study
  Eric A. Epping, James A. Mills, Leigh J. Beglinger, Jess G. Fiedorowicz, David Craufurd, Megan M. Smith, Mark Groves, Kelly R. Bijanki, Nancy R. Downing, Janet K. Will...> ;Journal of Psychiatric Research. 2013 Oct 1
• 34 citations
  An International Survey-based Algorithm for the Pharmacologic Treatment of Obsessive-Compulsive Behaviors in Huntington’s Disease
  Karen E. Anderson, David Craufurd, Mary Edmondson, Nathan Goodman, Mark Groves, Erik van Duijn, Daniel P. van Kammen, LaVonne Goodman> ;Plos Currents. 2011 Sep 20
• 38 citations
  An International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington's Disease.
  Jean-Marc Burgunder, Mark Guttman, Susan Perlman, Nathan Goodman, Daniel P van Kammen, Lavonne Goodman> ;Plos Currents. 2011 Aug 30
• 33 citations
  Mood and Cognition in Leucine-rich Repeat Kinase 2 G2019S Parkinson’s Disease
  Vicki Shanker, Mark Groves, Gary A. Heiman, Christina Palmese, Rachel Saunders-Pullman, Laurie J. Ozelius, Deborah Raymond, Susan Bressman> ;Movement Disorders. 2011 Aug 15
• 7 citations
  Assessing behavioural manifestations prior to clinical diagnosis of Huntington disease: "anger and irritability" and "obsessions and compulsions"
  Anthony L. Vaccarino, Karen E. Anderson, Beth Borowsky, Emil F. Coccaro, David Craufurd, Jean Endicott, J Giuliano, Mark Groves, Mark Guttman, Aileen K Ho, Peter Kupch...> ;Plos Currents. 2011 Jul 11
• 14 citations
  Assessment of depression, anxiety and apathy in prodromal and early Huntington disease
  Anthony L. Vaccarino, Terrence Sills, Karen Anderson, Anne-Catherine Bachoud-Lévi, Beth Borowsky, David Craufurd, Kevin Duff, J Giuliano, Mark Groves, Mark Guttman, Pe...> ;Plos Currents. 2011 Jun 17
• 4 citations
  Parkinson's disease as a model for psychosocial issues in chronic neurodegenerative disease.
  Mark Groves, David V Forrest> ;Advances in Neurology. 2005 Jan 1
• Profile of adult rat sensory neuron loss, apoptosis and replacement after sciatic nerve crush.
  Groves MJ, Schänzer A, Simpson AJ, An S, Kuo LT, Scaravilli F> ;J. Neurocytol.. 2003-02-01
• Expression of three oligosaccharide conjugates by neonatal rat dorsal root ganglion neurons: comparison with CGRP and GAP43 immunoreactivity.
  Groves MJ, Martinian L, An SF, Scaravilli F> ;J. Anat.. 1999-08-01
• Inhibition of sensory neuron apoptosis and prevention of loss by NT-3 administration following axotomy.
  Groves MJ, An SF, Giometto B, Scaravilli F> ;Exp. Neurol.. 1999-02-01
• Axotomy-induced apoptosis in adult rat primary sensory neurons.
  Groves MJ, Christopherson T, Giometto B, Scaravilli F> ;J. Neurocytol.. 1997-09-01
• Sciatic nerve injury in the adult rat: comparison of effects on oligosaccharide, CGRP and GAP43 immunoreactivity in primary afferents following two types of trauma.
  Groves MJ, Ng YW, Ciardi A, Scaravilli F> ;J. Neurocytol.. 1996-03-01
• An International Survey-based Algorithm for the Pharmacologic Treatment of Irritability in Huntington's Disease.
  Groves, M.,van Duijn, E.,Anderson, K.,Craufurd, D.,Edmondson, M. C.,Goodman, N.,van Kammen, D. P.,Goodman, L.> ;PLoS Curr. 2011 Oct 07
• Join now to see all